» Articles » PMID: 23108156

P63 Control of Desmosome Gene Expression and Adhesion is Compromised in AEC Syndrome

Overview
Journal Hum Mol Genet
Date 2012 Oct 31
PMID 23108156
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Ankyloblepharon, ectodermal defects, cleft lip/palate (AEC) syndrome is a rare autosomal dominant disorder caused by mutations in the p63 gene, essential for embryonic development of stratified epithelia. The most severe cutaneous manifestation of this disorder is the long-lasting skin fragility associated with severe skin erosions after birth. Using a knock-in mouse model for AEC syndrome, we found that skin fragility was associated with microscopic blistering between the basal and suprabasal compartments of the epidermis and reduced desmosomal contacts. Expression of desmosomal cadherins and desmoplakin was strongly reduced in AEC mutant keratinocytes and in newborn epidermis. A similar impairment in desmosome gene expression was observed in human keratinocytes isolated from AEC patients, in p63-depleted keratinocytes and in p63 null embryonic skin, indicating that p63 mutations causative of AEC syndrome have a dominant-negative effect on the wild-type p63 protein. Among the desmosomal components, desmocollin 3, desmoplakin and desmoglein 1 were the most significantly reduced by mutant p63 both at the RNA and protein levels. Chromatin immunoprecipitation experiments and transactivation assays revealed that p63 controls these genes at the transcriptional level. Consistent with reduced desmosome function, AEC mutant and p63-deficient keratinocytes had an impaired ability to withstand mechanical stress, which was alleviated by epidermal growth factor receptor inhibitors known to stabilize desmosomes. Our study reveals that p63 is a crucial regulator of a subset of desmosomal genes and that this function is impaired in AEC syndrome. Reduced mechanical strength resulting from p63 mutations can be alleviated pharmacologically by increasing desmosome adhesion with possible therapeutic implications.

Citing Articles

promising immunotherapeutic intervention for diseases.

Stefan K, Gordon R, Rolig A, Honkala A, Tailor D, Davis L Front Immunol. 2024; 15:1450118.

PMID: 39534596 PMC: 11554463. DOI: 10.3389/fimmu.2024.1450118.


Central subfield thickness of diabetic macular edema: Correlation with the aqueous humor proteome.

Cehofski L, Kojima K, Kusada N, Hansen M, Muttuvelu D, Bakker N Mol Vis. 2024; 30:17-35.

PMID: 38586604 PMC: 10994682.


Effects of TP63 mutations on keratinocyte adhesion and migration.

Salois M, Gugger J, Webb S, Sheldon C, Parraga S, Michael Lewitt G Exp Dermatol. 2023; 32(9):1575-1581.

PMID: 37432020 PMC: 10529328. DOI: 10.1111/exd.14885.


Disease-related p63 DBD mutations impair DNA binding by distinct mechanisms and varying degree.

Osterburg C, Ferniani M, Antonini D, Frombach A, DAuria L, Osterburg S Cell Death Dis. 2023; 14(4):274.

PMID: 37072394 PMC: 10113246. DOI: 10.1038/s41419-023-05796-y.


The Splicing Factor PTBP1 Represses Isoform Production in Squamous Cell Carcinoma.

Taylor W, Deschamps S, Reboutier D, Paillard L, Mereau A, Audic Y Cancer Res Commun. 2023; 2(12):1669-1683.

PMID: 36970727 PMC: 10035508. DOI: 10.1158/2767-9764.CRC-22-0350.


References
1.
Barbieri C, Barton C, Pietenpol J . Delta Np63 alpha expression is regulated by the phosphoinositide 3-kinase pathway. J Biol Chem. 2003; 278(51):51408-14. DOI: 10.1074/jbc.M309943200. View

2.
Laurikkala J, Mikkola M, James M, Tummers M, Mills A, Thesleff I . p63 regulates multiple signalling pathways required for ectodermal organogenesis and differentiation. Development. 2006; 133(8):1553-63. DOI: 10.1242/dev.02325. View

3.
Ingraham C, Kinoshita A, Kondo S, Yang B, Sajan S, Trout K . Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet. 2006; 38(11):1335-40. PMC: 2082114. DOI: 10.1038/ng1903. View

4.
Botti E, Spallone G, Moretti F, Marinari B, Pinetti V, Galanti S . Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas. Proc Natl Acad Sci U S A. 2011; 108(33):13710-5. PMC: 3158164. DOI: 10.1073/pnas.1110931108. View

5.
Rinne T, Clements S, Lamme E, Duijf P, Bolat E, Meijer R . A novel translation re-initiation mechanism for the p63 gene revealed by amino-terminal truncating mutations in Rapp-Hodgkin/Hay-Wells-like syndromes. Hum Mol Genet. 2008; 17(13):1968-77. DOI: 10.1093/hmg/ddn094. View